185 related articles for article (PubMed ID: 11716847)
1. Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.
Cuzzocrea S; Mazzon E; Serraino I; Dugo L; Centorrino T; Ciccolo A; Sautebin L; Caputi AP
Eur J Pharmacol; 2001 Nov; 431(1):91-102. PubMed ID: 11716847
[TBL] [Abstract][Full Text] [Related]
2. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.
Cuzzocrea S; McDonald MC; Mazzon E; Mota-Filipe H; Centorrino T; Terranova ML; Ciccolo A; Britti D; Caputi AP; Thiemermann C
Gut; 2001 Apr; 48(4):478-88. PubMed ID: 11247891
[TBL] [Abstract][Full Text] [Related]
3. The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat.
Cuzzocrea S; McDonald MC; Mazzon E; Mota-Filipe H; Lepore V; Ciccolo A; Terranova ML; Britti D; Caputi AP; Thiemermann C
Lab Invest; 2000 Sep; 80(9):1439-53. PubMed ID: 11005212
[TBL] [Abstract][Full Text] [Related]
4. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
Cuzzocrea S; Mazzon E; Serraino I; Lepore V; Terranova ML; Ciccolo A; Caputi AP
J Pineal Res; 2001 Jan; 30(1):1-12. PubMed ID: 11168901
[TBL] [Abstract][Full Text] [Related]
5. Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis.
Cuzzocrea S; McDonald MC; Mazzon E; Dugo L; Lepore V; Fonti MT; Ciccolo A; Terranova ML; Caputi AP; Thiemermann C
Eur J Pharmacol; 2000 Oct; 406(1):127-37. PubMed ID: 11011044
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
7. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
[TBL] [Abstract][Full Text] [Related]
8. GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat.
Mazzon E; Dugo L; Li JH; Di Paola R; Genovese T; Caputi AP; Zhang J; Cuzzocrea S
Biochem Pharmacol; 2002 Jul; 64(2):327-37. PubMed ID: 12123754
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin reduces the development of experimental inflammatory bowel disease.
Cuzzocrea S; Mazzon E; Di Paola R; Patel NS; Genovese T; Muià C; De Sarro A; Thiemermann C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1272-80. PubMed ID: 15302898
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis.
Cuzzocrea S; Mazzon E; Dugo L; Caputi AP; Riley DP; Salvemini D
Eur J Pharmacol; 2001 Nov; 432(1):79-89. PubMed ID: 11734191
[TBL] [Abstract][Full Text] [Related]
11. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.
Cuzzocrea S; Ianaro A; Wayman NS; Mazzon E; Pisano B; Dugo L; Serraino I; Di Paola R; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Feb; 138(4):678-88. PubMed ID: 12598422
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
Impellizzeri D; Bruschetta G; Di Paola R; Ahmad A; Campolo M; Cuzzocrea S; Esposito E; Navarra M
Clin Nutr; 2015 Dec; 34(6):1146-54. PubMed ID: 25491246
[TBL] [Abstract][Full Text] [Related]
13. Natural almond skin reduced oxidative stress and inflammation in an experimental model of inflammatory bowel disease.
Mandalari G; Bisignano C; Genovese T; Mazzon E; Wickham MS; Paterniti I; Cuzzocrea S
Int Immunopharmacol; 2011 Aug; 11(8):915-24. PubMed ID: 21354356
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminoisoquinolinone reduces colon injury by experimental colitis.
Cuzzocrea S; Mazzon E; Di Paola R; Genovese T; Patel NS; Muià C; Threadgill MD; De Sarro A; Thiemermann C
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):464-73. PubMed ID: 15599708
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid.
Di Paola R; Mazzon E; Patel NS; Genovese T; Muià C; Thiemermann C; De Sarro A; Cuzzocrea S
Eur J Pharmacol; 2005 Jan; 507(1-3):281-9. PubMed ID: 15659319
[TBL] [Abstract][Full Text] [Related]
16. Green tea polyphenol extract attenuates colon injury induced by experimental colitis.
Mazzon E; Muià C; Paola RD; Genovese T; Menegazzi M; De Sarro A; Suzuki H; Cuzzocrea S
Free Radic Res; 2005 Sep; 39(9):1017-25. PubMed ID: 16087483
[TBL] [Abstract][Full Text] [Related]
17. Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
Cordaro M; Impellizzeri D; Gugliandolo E; Siracusa R; Crupi R; Esposito E; Cuzzocrea S
Mol Pharmacol; 2016 Nov; 90(5):549-561. PubMed ID: 27625036
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat.
Cuzzocrea S; Mazzon E; Sautebin L; Dugo L; Serraino I; De Sarro A; Caputi AP
Biochem Pharmacol; 2002 Feb; 63(4):785-95. PubMed ID: 11992649
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of exacerbation of colonic damage in experimental colitis treated with celecoxib].
Zhang L; Lv Ym; Ye Sm; Dong Xy
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):195-9. PubMed ID: 18458699
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.
Ko JK; Lam FY; Cheung AP
World J Gastroenterol; 2005 Oct; 11(37):5787-94. PubMed ID: 16270386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
